Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Nelson

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Urology|June 28, 2000
Evaluation of the effect of spinal cord injury on serum PSA levelsB R Konety, T T Nguyen, G Brenes, et al.
The Prostate|May 8, 2001
Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progressionE S Pizer, B R Pflug, G S Bova, et al.
Nature Medicine|September 1, 1995
Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostateJ B Nelson, S P Hedican, D J George, et al.
Cancer Research|February 15, 1996
Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancerJ B Nelson, K Chan-Tack, S P Hedican, et al.
Urology|December 22, 1999
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumorsJ B Nelson, R N Chen, J T Bishoff, et al.
Urology|May 1, 1999
New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockadeJ B Nelson, S H Nguyen, J R Wu-Wong, et al.
Cancers|August 12, 2023
A Theranostic Approach to Imaging and Treating Melanoma with <sup>203</sup>Pb/<sup>212</sup>Pb-Labeled Antibody Targeting MelaninRubin Jiao, Kevin J H Allen, Mackenzie E Malo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Methylation of the neutral endopeptidase gene promoter in human prostate cancersB A Usmani, R Shen, M Janeczko, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
Gene Therapy|August 1, 2008
Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injuryR Kato, D Wolfe, C H Coyle, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Urology|June 28, 2000
Evaluation of the effect of spinal cord injury on serum PSA levelsB R Konety, T T Nguyen, G Brenes, et al.
The Prostate|May 8, 2001
Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progressionE S Pizer, B R Pflug, G S Bova, et al.
Nature Medicine|September 1, 1995
Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostateJ B Nelson, S P Hedican, D J George, et al.
Cancer Research|February 15, 1996
Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancerJ B Nelson, K Chan-Tack, S P Hedican, et al.
Urology|December 22, 1999
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumorsJ B Nelson, R N Chen, J T Bishoff, et al.
Urology|May 1, 1999
New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockadeJ B Nelson, S H Nguyen, J R Wu-Wong, et al.
Cancers|August 12, 2023
A Theranostic Approach to Imaging and Treating Melanoma with <sup>203</sup>Pb/<sup>212</sup>Pb-Labeled Antibody Targeting MelaninRubin Jiao, Kevin J H Allen, Mackenzie E Malo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Methylation of the neutral endopeptidase gene promoter in human prostate cancersB A Usmani, R Shen, M Janeczko, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
Gene Therapy|August 1, 2008
Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injuryR Kato, D Wolfe, C H Coyle, et al.
Pageof 12